Biologics

Burst Biologics, based in Boise, Idaho, is a regenerative medicine company.

Orthopedic surgeons continue to express concerns over various stem cell treatments being offered to patients, according to Contact7.

Insurers will not usually pay for unproven stem cell treatments, so patients seeking those interventions must pay out-of-pocket or use social media to receive donations, a practice known as crowdfunding. Medical crowdfunding campaigns may convey misleading messages about stem cell-based…

NuVasive's biologics portfolio includes AttraX Putty.

Osteoarthritis-mesenchymal stem cells may drive cartilage degeneration pathogenesis and should be targeted in osteoarthritis therapy, according to a study in Scientific Reports.

Researchers successfully grafted induced pluripotent stem cell-derived neural precursor cells into the spinal cords of pigs with and without spinal cord injury with only temporary immunosuppression, according to a study in Science Translational Medicine.

The U.S. Department of Justice filed lawsuits to shut down stem cell clinics in Florida and California that marketed unapproved stem cell treatments, the Los Angeles Times reports.

Transplanted human spinal cord-derived neural stem cells may stabilize functioning in amyotrophic lateral sclerosis patients, according to a study in the Annals of Clinical and Translational Neurology.

The global spine biologics market will likely grow at a compound annual growth rate of 4.5 percent between 2018 and 2023, based on a Market.biz report, according to Business News.

Bone Biologics, based in Burlington, Mass., is a publicly traded company focused on orthobiologic solutions.